Hexabromocyclododecane-induced Genotoxicity in Cultured Human Breast Cells through DNA Damage

Biomed Environ Sci. 2017 Apr;30(4):296-300. doi: 10.3967/bes2017.039.

Abstract

To investigate the genotoxicity and reveal the potential toxicological mechanisms of Hexabromocyclododecane (HBCD), human breast cells HBL-100 were exposed to a sequence of HBCD concentrations (0, 5, 10, and 50 mg/L) for 24 h. With a series of zymology and molecular biology methods, we found that HBCD induced dose-dependent oxidative stress on HBL-100 DNA. As revealed in qRT-PCR, activated prognostic factor ATM down-regulated tumor suppressor gene BRCA1 and prompted DNA repair genes hOGG1 and hMTH1 expression in lower concentrations of HBCD (< 10 mg/L). However, DNA repair were inhibited as well as cell proliferation rate by higher concentrations of HBCD (50 mg/L). The results inferred that the genotoxicity of HBCD was dose-dependent and related to DNA repair pathway.

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms / chemically induced
  • Breast Neoplasms / genetics*
  • Cell Line, Tumor
  • DNA Damage
  • Dose-Response Relationship, Drug
  • Environmental Pollutants / toxicity*
  • Female
  • Flame Retardants / toxicity*
  • Humans
  • Hydrocarbons, Brominated / toxicity*
  • Oxidative Stress
  • Random Allocation

Substances

  • Environmental Pollutants
  • Flame Retardants
  • Hydrocarbons, Brominated
  • hexabromocyclododecane